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Abstract
This review highlights recent research on the properties and functions of the enzyme transketolase, which requires
thiamin diphosphate and a divalent metal ion for its activity. The transketolase-catalysed reaction is part of the
pentose phosphate pathway, where transketolase appears to control the non-oxidative branch of this pathway,
although the overall flux of labelled substrates remains controversial. Yeast transketolase is one of several thiamin
diphosphate dependent enzymes whose three-dimensional structures have been determined. Together with
mutational analysis these structural data have led to detailed understanding of thiamin diphosphate catalysed
reactions. In the homodimer transketolase the two catalytic sites, where dihydroxyethyl groups are transferred from
ketose donors to aldose acceptors, are formed at the interface between the two subunits, where the thiazole and
pyrimidine rings of thiamin diphosphate are bound. Transketolase is ubiquitous and more than 30 full-length
sequences are known. The encoded protein sequences contain two motifs of high homology; one common to all
thiamin diphosphate-dependent enzymes and the other a unique transketolase motif. All characterised transketolases
have similar kinetic and physical properties, but the mammalian enzymes are more selective in substrate utilisation
than the nonmammalian representatives. Since products of the transketolase-catalysed reaction serve as precursors
for a number of synthetic compounds this enzyme has been exploited for industrial applications. Putative mutant
forms of transketolase, once believed to predispose to disease, have not stood up to scrutiny. However, a
modification of transketolase is a marker for Alzheimer’s disease, and transketolase activity in erythrocytes is a
measure of thiamin nutrition. The cornea contains a particularly high transketolase concentration, consistent with
the proposal that pentose phosphate pathway activity has a role in the removal of light-generated radicals. # 1998
Elsevier Science Ltd. All rights reserved.
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1. Transketolase: a thiamin diphosphate dependent
enzyme
Thiamin diphosphate (ThDP) is a derivative of
thiamin, the first vitamin to be isolated in pure
form [71]. In 1937 Lohmann and Schuster [95]
discovered that ThDP is the ‘‘active’’ thiamin
cofactor in the enzyme pyruvate decarboxylase
(PDC) from yeast. Since then ThDP has been
recognised as a cofactor in several enzymes,
which catalyse mainly decarboxylations of a-
ketoacids or the transfer of ketol groups from
donor ketoses to acceptor aldoses.
The chemical structure of ThDP is that of an
aromatic methylaminopyrimidine ring, linked via
a methylene bridge to a methylthiazolium ring
with a pyrophosphate group attached to a hydro-
xyethyl side chain (Fig. 1). In non-enzymatic
model studies it has been demonstrated that the
thiazolium ring can catalyse reactions which are
similar to those of ThDP-dependent enzymes but
several orders of magnitude slower [86, 104, 185].
Using infrared and NMR spectrophotometry it
has been shown that the dissociation of the pro-
ton from C2 of the thiazolium ring is necessary
for catalysis; the abstraction of the proton leads
to the formation of a carbanion (ylid) with the
potential for a nucleophilic attack on the carbo-
nyl group of the substrate [12–14]. It proved to
be dicult to determine the pKa of the C2 atom
directly, mainly because of base-catalysed reac-
tions in water that lead to a ring-opening of
thiamin [33, 62, 97]. Hopmann and Brugnoni [61]
reported a pKa of 12.7, but Bunting [15] has
suggested that the actual pKa is closer to 20, con-
sistent with the value (16.9–18.9) reported more
recently by Washabaugh and Jencks [173].
Several reviews have discussed the catalytic
function of ThDP [38, 80, 136, 142, 169]. In all
ThDP-dependent enzymes the abstraction of the
proton from the C2 atom is the first step in cata-
lysis, which is followed by a nucleophilic attack
of this carbanion on the substrate. Subsequent
cleavage of a C–C bond releases the first product
with formation of a second carbanion (2-a-carba-
nion or enamine). The formation of this 2-a-car-
banion is the second feature of ThDP catalysis
common to all ThDP-dependent enzymes.
Depending on the enzyme and the substrate(s),
the reaction intermediates and products dier.
A sequence motif common to all known
ThDP-dependent enzymes has been suggested to
represent the ThDP-binding site [52, 127]. The
consensus sequence for this motif in TK (Fig. 2)
begins with the highly conserved residues Gly-
Asp-Gly (GDG) followed by 21 residues with
less homology. The motif ends with an invariant
asparagine, preceded by a stretch of several
mainly hydrophobic residues. The secondary
structure predicted for this motif is that the
GDG sequence forms a turn that separates a
b strand from an a helix approximately 20
residues in length. The conserved asparagine
at the C-terminal end of this motif is predicted
to form another turn that separates this a
helix from another b strand. Crystal
Fig. 1. Structure of thiamin and ThDP. The methylaminopyri-
nidine ring (MAP) is linked via a methylene bridge to the
methylthiazolium ring (MT). In thiamin R is a hydrogen
atom and in ThDP R is a pyrophosphate moiety (P2O
3ÿ
6 ). The
arrow points towards the C2, the active centre of ThDP-cata-
lysed reactions.
Fig. 2. ‘‘ThDP-binding’’ motif of TKs. The sequences are
taken from the multiple alignment of 22 TK sequences in
Schenk et al. [138]. Only four sequences representing mamma-
lian (Hsa: human [138]), plant (Cpl3: Craterostigma
plantagineum [4]), fungal (Sce: Saccharomyces cerevisiae [155])
and bacterial (Eco: Escherischia coli [152]) sources have been
selected for illustration. The consensus sequence based on the
entire alignment in Schenk et al. [138] is shown; x can be any
amino acid.
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structures [3, 30, 51, 93, 108, 111] and site-directed
mutagenesis studies [18, 28, 171] have revealed
that selected residues within the motif anchor the
diphosphate group of ThDP through the divalent
cation; no motif residue interacts directly with
the thiazole and pyrimidine portions of the cofac-
tor.
The three-dimensional structures of several
ThDP-dependent enzymes have been determined;
these are Saccharomyces cerevisiae transketolase
(TK) [93, 111], Lactobacillus plantarum pyruvate
oxidase (POX) [108], S. uvarum pyruvate decar-
boxylase (PDC) [30], S. cerevisiae PDC [3] and
Pseudomonas putida benzoylformate decarboxy-
lase (BDC) [51]. Three distinct domains can be
discerned in each of these structures. In PDC,
POX and BDC the motif common to all ThDP-
dependent enzymes is located in the C-terminal
domain, but it is in the N-terminal domain of
TK. Interestingly, while PDC, POX and BDC
have a collinear arrangement of domains, TK
seems to be a circular permutation of the others
in which the first and second domains of TK cor-
respond to the third and first domains of the
three other enzymes [109]. Robinson and
Chun [129] came to similar conclusions based
upon a sequence alignment which included the
subunits of the E1 enzyme of the pyruvate dehy-
drogenase (PDH) complexes from human,
Bacillus stearothermophilus and Escherichia coli
sources.
The observed structural and, to a lesser extent,
sequence homology as well as the similarity of
the catalytic mechanism of all characterised
ThDP-dependent enzymes might reflect a com-
mon ancestry [48] followed by insertions, del-
etions, duplications and other mutations during
the course of evolution. Recently, Pohl reviewed
PDC [122]. An early review of TK has been pub-
lished by Racker in 1961 [125] and Kochetov
(1986) has summarised structural and mechanistic
aspects of TK from baker’s yeast [83]. Since then
structural and sequence data have greatly
increased. Here we discuss the properties and
functions of TK, putting recent data in context
with earlier work.
2. Occurrence and properties of TK
2.1. Sources of TK
TK occurs in all organisms in which it has
been investigated. The enzyme has been at least
partially purified from a variety of sources
including baker’s yeast [25, 65, 154], Candida
utilis [77, 79], spinach [165], pig liver [120, 147],
rat liver [116], rabbit liver [98], mouse brain [8],
human leukocytes [105] and human
erythrocytes [1, 10, 56, 58, 135, 158, 170]. Recently,
TK has been purified from E. coli [37, 153].
Dihydroxyacetone synthase (DHAS), a special
TK present in organisms growing on methanol,
has been purified from C. boidinii [74, 167] and
from the carboxydobacterium Acetinobacter
sp. [128], and it is likely to be present in the acti-
nomycete Amycolatopsis methanolica [2].
Genes coding for DHAS from the methanol-
utilising yeast Hansenula polymorpha [70] and TK
from several mammals [1, 100, 138, 141],
yeasts [69, 102, 155], bacteria [e.g. 21, 134, 152]
and plants [e.g. 4] have been cloned and/or
sequenced. Currently, more than 30 full length or
nearly full length sequences are available from
GenBank. Two genes coding for distinctly dier-
ent but closely related TKs have been cloned
from S. cerevisiae [132, 155] and E. coli [68, 152];
three dierent forms of TK have been cloned
from the desiccation-tolerant plant Craterostigma
plantagineum [4].
Most of the kinetic and physicochemical stu-
dies of TK have focussed on the enzyme from
human [10, 11, 56, 149, 161, 170], E. coli [37, 153]
and S. cerevisiae [10, 32, 55, 83, 112, 175–177]. The
three-dimensional structure of the latter
enzyme [93, 111] has been published (PDB acces-
sion code 1TRK) and crystallographic studies on
the E. coli enzyme have commenced [94].
Homologous expression systems are established
for the S. cerevisiae [155] and the E. coli [60, 153]
enzyme. For human TK two laboratories have
reported [140] or made use of a bacterial heter-
ologous expression system [149, 171]. The
enzymes from other sources have been less well
studied but most known characteristics are gener-
ally similar between all known TKs. Nonetheless,
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there are dierences and some of those are dis-
cussed below.
2.2. Substrate specificity
A broad range of substrates has been reported
for the TKs from yeasts, plants and bacteria. TK
from S. cerevisiae can utilise sugars such as D-
xylulose 5-phosphate, D-sedoheptulose 7-phos-
phate, D-fructose 6-phosphate and D-erythrulose
4-phosphate, as well as dihydroxyacetone phos-
phate, dihydroxyacetone and hydroxypyruvate as
donors of the transferred glycolaldehyde group.
Acceptor substrates include D-ribose 5-phos-
phate, D-glyceraldehyde 3-phosphate, D-ery-
throse 4-phosphate and glycolaldehyde [83, 162].
TK from spinach leaves has a substrate speci-
ficity similar to that of the S. cerevisiae
enzyme [165] and can also catalyse the transfer of
a two-carbon fragment from hydroxypyruvate
to non-phosphorylated acceptor sugars. Recent
findings indicate that TK purified from E. coli
displays substrate specificities similar to those of
the reported yeast and plant TKs [153]. In con-
trast, mammalian TKs are somewhat more
specific, using only D-xylulose 5-phosphate,
D-fructose 6-phosphate and D-sedoheptulose 7-
phosphate as donors, and D-ribose 5-phosphate,
D-erythrose 4-phosphate, D-glyceraldehyde
3-phosphate and glycolaldehyde as acceptor
substrates [105, 115, 137, 170]. The Km values for
TK from dierent sources and for several of the
main substrates are listed in Table 1. Table 2
shows Km values for spinach TK with unpho-
sphorylated substrates. It is apparent that the
anity of the enzyme for unphosphorylated sub-
strates is low. This finding is consistent with the
observation that the phosphate group of the sub-
strates interacts with TK resulting in tighter
binding [112]. However, the fact that spinach TK
can utilise D-xylose as a substrate makes this
enzyme an interesting candidate for potential use
in biotransformations, although the Michaelis
constant for this substrate is high (230 mM,
Table 2). D-xylose occurs abundantly in nature;
however, attempts to construct an industrial fer-
mentation system for the large-scale production
of ethanol from this carbohydrate have not been
very successful [e.g. 168, 186]. A recombinant
yeast strain expressing spinach TK may improve
D-xylose fermentation significantly. Less data are
available for DHAS; the enzyme from H. poly-
morpha, C. boidinii and Acetinobacter sp. displays
an even wider range of substrate specificity,
including all of the substrates mentioned for
yeast TK, as well as formaldehyde and acet-
aldehyde as acceptors [70, 74, 128]. It appears [74]
that the Michaelis constants for the donor (D-
xylulose 5-phosphate, 1 mM) and acceptor (for-
maldehyde, 0.43 mM) substrates are similar to
those measured for the substrates of TK
(Table 1). In general, the in vivo concentration of
most of the TK (and DHAS) substrates is, as far
as has been determined, in the range between one
and 100 mM [e.g. 184], whereas the Km values are
generally at least one order of magnitude larger
(Table 1). Thus, under the physiological range of
substrate concentrations TK enzyme activity will
be approximately proportional to substrate con-
centration.
TK has a potential for use in industrial appli-
cations (see below). For an eective application
Table 1
Km values for selected substrates for TK from various sources, representing mammalian, fungal, plant and bacterial enzymes. Data
for the human enzyme were taken from Waltham [170]. All non human data are quoted from the collection of Sprenger et al. [153]
Source Human S. cerevisiae Spinach E. coli
Xylulose 5-phosphate 0.49 mM 0.21 mM not available 0.16 mM
Ribose 5-phosphate 0.53 mM 0.4 mM 0.4 mM 1.4 mM
Fructose 6-phosphate 7 mM 1.8 mM 3.2 mM 1.1 mM
Glyceraldehyde 3-phosphate not available 4.9 mM not available 2.1 mM
Erythrose 4-phosphate 0.36 mM not available not available 0.09 mM
Hydroxy-pyruvate no activity 33 mM not available 18 mM
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in large-scale production the conditions which
may aect the reaction need to be known. Such
information includes the Km for the substrates
and the inhibition constant (Ki) for each of the
products. Moreover, since TK has a ping-pong
kinetic mechanism [22] in which substrates can
bind to the ‘‘wrong’’ enzyme form, there is the
potential for substrate inhibition as well.
Hydroxypyruvate is likely to be a preferred
donor substrate because by eective removal of
the first product, CO2 (product 1 in Fig. 3), the
reaction becomes essentially irreversible. The Km
and Ki values of E. coli TK for this substrate are
18 mM (Table 1) and 42 mM [50], respectively.
In trial experiments designed to optimise the con-
ditions for utilising TK in biotransformations
glycolaldehyde was used as an acceptor
substrate [50, 103], resulting in the production of
L-erythrulose. The Michaelis and substrate inhi-
bition constants for glycolaldehyde are 16 mM
and 600 mM, respectively [50]. The product L-
erythrulose inhibits the forward reaction only
weakly (Ki of 565 mM) [50]. However, it was
also reported that incubation of E. coli TK over
a period of 8 h with glycolaldehyde at a concen-
tration of 500 mM resulted in irreversible loss of
60% activity [103]. Thus, for continuous large-
scale operation a bioreactor needs to be designed
which maintains the concentrations of the reac-
tants and products in well defined limits (e.g. [9]);
in the case of the above mentioned model reac-
tion the donor and acceptor substrate concen-
trations should not greatly exceed 40 mM and
100 mM, respectively [50], whereas product ac-
cumulation up to a concentration of 500 mM
does not significantly interfere with the progress
of the reaction.
TK, together with transaldolase (TA), catalyses
reactions in the non-oxidative branch of the pen-
tose phosphate pathway (PPP) (Fig. 4) [183].
Based mainly on carbon balance studies and on
experiments involving tracing of 14C labelled
sugars, Williams and coworkers have proposed
an alternative version of the PPP, the so called
‘‘L-type’’, which apparently operates in hepato-
cytes from rats [178]. In this type of the PPP glu-
cose 6-phosphate also acts as an acceptor
substrate for TK, resulting in the generation of
an octulose [66, 179, 180]. These findings have
remained controversial. Landau and Wood [91]
analysed the work of Williams and collaborators
in detail. While they reported several inconsisten-
cies in Williams’ interpretation of his data they
also listed several other studies which do not sup-
port the existence of an ‘‘L-type’’ PPP (see [91]
and cited literature therein). Additionally, at con-
centrations up to 10 mM glucose 6-phosphate
does not act as a substrate for human TK puri-
fied from erythrocytes [170], whereas the concen-
tration of glucose 6-phosphate in red blood cells
is approximately 40 mM [184]. Interestingly, in
the desiccation-tolerant plant C. plantagineum the
stress-induced expression of two TK isoforms is
accompanied by an accumulation of an octulose
during rehydration [4]. Thus, while the alterna-
tive type of the PPP may not operate in mamma-
lian tissues, its existence in plants cannot be
ruled out.
2.3. Oligomeric structure
The functional form isolated from baker’s
yeast [25, 154] is a homodimer of 74 kDa sub-
units, each of which contains a molecule of
ThDP [83]. The crystal structure of this enzyme
has confirmed this observation [93, 111]. While
the two cofactor binding sites are identical
according to the crystal structure, it has been
speculated that a conserved hydrogen bonding
pattern between the two ThDP molecules may fa-
cilitate cooperative interactions between the two
active sites in TK [111]. Consistent with this hy-
pothesis kinetic studies have revealed that TK
displays kinetic inequivalence of the active sites
resulting in negative cooperativity with respect to
ThDP binding [32, 85]. TK purified from the
yeast C. utilis [79], rat [63], rabbit [98],
Table 2
Km values for unphosphorylated substrates of TK from spi-
nach leaves. Data are quoted from Villafranca and
Axelrod [165]
Substrate D-ribose L-lyxose L-arabinose D-xylose
Km 45 mM 55 mM 120 mM 230 mM
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human [56] and the plant C. plantagineum [4] are
also homodimeric. Using gel filtration and sedi-
mentation analysis Villafranca and Axelrod [165]
demonstrated that TK extracted from spinach
leaves apparently exists in monomeric form with
a subunit molecular weight of approximately
100 kDa. However, the recent determination of
the sequence of spinach TK [36] revealed that the
subunit molecular weight is approximately
74 kDa, similar to that of other plant TKs.
Moreover, a phylogenetic analysis by the same
group showed that the spinach enzyme is most
closely related to the constitutively expressed
enzyme from C. plantagineum (Cpl3, [4]). Based
Fig. 3. Catalytic mechanism for TK. TK catalyses the transfer of the dihydroxyethyl group from a ketose donor (substrate 1) to an
aldose acceptor (substrate 2). The catalytic reaction is initiated by the deprotonation of C2 of the methylthiazolium ring. This car-
banion (ThDP ylide) then attacks the ketose substrate leading to the formation of the labile intermediate 1. Release of the first
reaction product and tautomerisation of the resulting enamine generates a second carbanion (DHEThDP), which interacts with the
aldose substrate. Release of the second product finally regenerates the active centre, which is now ready for the next cycle of cataly-
sis.
G. Schenk et al. / The International Journal of Biochemistry & Cell Biology 30 (1998) 1297–13181302
on similarities of spinach and C. plantagineum
TKs in function and sequence it is likely that the
native spinach enzyme also forms a homodimer.
Treatment of a homogeneous holoTK prep-
aration from pig liver with SDS and 2-mercap-
toethanol in the presence of the protease
inhibitor PMSF resulted in two bands on a poly-
acrylamide gel with molecular weights of 52 kDa
to 56 kDa (a-subunit) and 27 kDa to 29 kDa (b-
subunit) [120]. Based on these results it was con-
cluded that native pig liver TK forms a heterote-
tramer (a2b2) with a molecular weight of
138 kDa (determined by sedimentation equili-
brium studies) [120]. However, incubation of the
two isolated subunits in the presence of ThDP
did not result in active TK holoenzyme [120].
Considering that all remaining characterised
mammalian TKs are homodimers with a molecu-
lar weight of approximately 140 kDa, and all
known mammalian TK sequences are highly
conserved [138] it is doubtful that the pig liver
enzyme diers significantly; the sequence of this
TK is yet to be determined.
DHAS from C. boidinii is apparently a homo-
tetramer with a subunit molecular weight of
55 kDa [74]. This is significantly smaller than
that of DHAS from H. polymorpha [70].
Recently, DHAS has been purified from
Acetinobacter sp. [128] using a protocol similar to
that applied to the purification of this enzyme
from C. boidinii [74]. However, the Acetinobacter
sp. enzyme appears to be a homodimer with a
subunit molecular mass of 73 kDa. At present,
the variation of the oligomeric structures of C.
boidinii DHAS on the one hand and the enzymes
from H. polymorpha and Acetinobacter sp. on the
other hand cannot be resolved conclusively.
However, based on the results of the abovemen-
tioned studies on TK and DHAS from a broad
range of sources, it appears that the general oli-
gomeric structure of this group of enzymes is
usually that of a homodimer with subunit mol-
ecular weights between 67 kDa and 75 kDa.
2.4. Stability and optimum pH for activity
Native human holoTK is remarkably stable.
Erythrocyte TK in crude extracts loses activity
only when it is repeatedly frozen and
thawed [150]; it remains active over two weeks
while undergoing purification at 248C [10]. When
whole blood was stored in acid dextrose at 58C,
the erythrocyte TK activity was not lost after
several days and at ÿ208C activity remained
stable for up to a month [181]. Human TK puri-
fied from brain retained 80%–90% of its initial
activity after storage at ÿ208C for one month,
and recombinant human TK, expressed in E.
Fig. 4. Selected reactions of the PPP. TK transfers two-carbon units from donor ketoses (xylulose 5-phosphate) to acceptor aldoses
(ribose 5-phosphate or erythrose 4-phosphate) resulting in the formation of aldose (glyceraldehyde 3-phosphate) and ketose (sedo-
heptulose 7-phosphate or fructose 6-phosphate) products. TA transfers three-carbon units from the ketose donor sedoheptulose 7-
phosphate to the aldose acceptor glyceraldehyde 3-phosphate. The net result of these three reactions is the formation of one mol-
ecule of glyceraldehyde 3-phosphate and two molecules of fructose 6-phosphate from three pentoses. Subsequently, the product
molecules can be further metabolised through the glycolytic pathway.
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coli, remained stable in the crude extract even
when stored at ambient temperatures for several
weeks [137]. The stability of human TK is great-
est at a pH between 7.5 and 10 [56]. The loss of
activity after incubation of a pure preparation of
this enzyme at 558C for 5 min was 50%; how-
ever, when albumin was added prior to the incu-
bation the loss was only 3% [158]. Heat-
treatment of a crude extract at 558C has been an
early step in some purification protocols for
human TK because it destroys the heat-labile
TA, whereas the loss of TK is small [157]. Pig
liver TK [120, 147] and rat liver TK [115] also
display relatively high stability with a pH opti-
mum between 7.8 and 8.2. In the presence of
4 mM ThDP incubation of the porcine enzyme
for one hour at 508C does not lead to any mea-
surable decrease in activity [120]. Rabbit liver
TK seems to be less stable than the other charac-
terised mammalian TKs; when stored at ÿ208C
in the presence of phenylmethylsulphonyl fluor-
ide, mercaptoethanol and EDTA, 46% of its ac-
tivity was irreversibly lost after 70 days [98].
The removal of ThDP from mammalian TKs
requires acidic conditions, whereas resolution of
the yeast [154], C. utilis [79] and E. coli [153]
enzyme occurs at alkaline pH. Consistently, puri-
fied baker’s yeast TK stored under alkaline con-
ditions appears to be less stable than the
mammalian ones. A loss of more than 30% of
the activity after two weeks was reported when
the enzyme was stored at ÿ208C in the presence
of glycerol and dithiothreitol (DTT) at
pH 7.9 [20]. However, when stored at ÿ208C as a
crystalline suspension in saturated ammonium
sulphate the enzyme remained stable for
months [82]. The purified enzyme from E. coli in
glycylglycine buer at pH 8.5 could be stored at
ÿ208C in the presence of DTT and 20% glycerol
for three months with less than 20% loss of
activity [153]. At 48C in glycylglycine buer at
pH 8.5 the loss of activity was approximately
10%/month. When kept at a lower pH in phos-
phate buer (pH 7.0) at ÿ208C E. coli TK in a
cleared lysate retained 100% of its activity for a
month [103].
The optimum pH for activity is similar in all
characterised TKs. For the enzymes from human
erythrocytes [56] and C. utilis [79] the optimal
pH is 7.7. A value between pH 7.5 and 7.6 has
been reported for TKs from baker’s and brewer’s
yeast [24, 130], as well as from spinach
leaves [165]. An optimal pH range between 7.4
and 8.2 has been observed for liver TK from var-
ious species [98, 115, 120, 147] and the E. coli
enzyme displays maximum activity in glycylgly-
cine buer at pH 8.0 to 8.5 [153] and between
pH 7.0 and 7.5 in phosphate buer [103].
2.5. Cofactor requirements
ThDP can be removed from baker’s yeast TK
under relatively mild, alkaline conditions [24].
After complete resolution the addition of ThDP
and a divalent cation are absolutely necessary to
restore catalytic activity [57]. It has also been
shown that a loss of activity can be prevented by
the addition of cofactors during the purification
of TKs from yeasts [20, 24, 57, 74, 124, 156], con-
sistent with the pH conditions of resolution pro-
cedures being similar to the pH conditions of
optimised purification protocols. In contrast, par-
tially purified mammalian TKs do not require
the addition of cofactors to maintain activity.
This observation suggests a greater anity of the
mammalian enzymes for the cofactors [56, 81, 98],
a proposition that is also reflected in the con-
ditions required for the resolution of these
enzymes [63, 72, 161], which is achieved at pH
values below 4 [10, 56, 170], well removed from
the pH conditions of purification procedures.
Purified holoTKs from yeasts and mam-
malian sources have been reported to con-
tain one molecule of ThDP per sub-
unit [46, 56, 72, 81, 98, 116, 120, 158], a result
which has been confirmed, at least for the S. cer-
evisiae enzyme, by the crystal structure [93, 111].
The necessity of divalent metal ions for activity
has been shown for baker’s yeast TK [57, 124].
The reconstitution rate of this enzyme increases
in the order Ni2+<Mg2+<Co2+<Mn2+
<Ca2+, but the final catalytic activity is indepen-
dent of the nature of the divalent metal ion [57].
A similar observation has been reported for E.
coli TK [153]. Initially, it was suggested that
mammalian TKs do not require any divalent cat-
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ions for activity [120, 172]. However, reconstitu-
tion studies in the presence of ethylendiaminete-
traacetic acid (EDTA) have demonstrated that a
divalent cation is absolutely necessary for
activity [72]; activity may be restored by Mg2+,
Ca2+, Mn2+ and Co2+, but not Zn2+ or Cu2+.
2.6. Sequence and evolutionary analysis
A detailed sequence comparison has shown
that the overall sequence homology between TKs
from divergent species is quite low [138].
Nonetheless, there are two regions with a high
degree of sequence similarity. The first one,
located in the N-terminal domain, is the motif
common to all ThDP-dependent enzymes
(Fig. 2) [52]. A second motif, which has an even
higher degree of sequence homology, was orig-
inally discovered because of its similarity to the
nucleotide binding motif of NADH-dependent
dehydrogenases [1]. Subsequent analysis has
shown that this motif (Fig. 5) is specific for TKs
and it has therefore been denoted the ‘‘TK
motif’’ [138].
A phylogenetic analysis of TK sequences has
revealed that this enzyme reflects taxonomic re-
lationships quite accurately. Its slow evolutionary
dynamics together with its ubiquitous distri-
bution may make this ancient enzyme a suitable
model for a molecular clock, in particular for
mammals [138].
3. Metabolic roles of TK
TK, together with TA, reversibly links glycoly-
sis to the PPP. TK catalyses the conversion of D-
xylulose 5-phosphate and D-ribose 5-phosphate
to D-glyceraldehyde 3-phosphate and D-sedohep-
tulose 7-phosphate (Fig. 4). It is recognised that
TK and TA together can form the products D-
fructose 6-phosphate and D-erythrose 4-phos-
phate, a precursor of aromatic amino acids.
Further, TK can catalyse the conversion of D-
xylulose 5-phosphate and D-erythrose 4-phos-
phate to D-glyceraldehyde 3-phosphate and D-
fructose 6-phosphate. TK transfers a two-carbon
unit (‘‘activated glycolaldehyde’’, intermediate 1
in Fig. 3), whereas TA, which does not contain a
prosthetic group, transfers a three-carbon unit
via the formation of a Schi base. The carbo-
hydrate that donates the two- or three-carbon
unit is always a ketose and the acceptor is always
an aldose. The reactions recognised as the PPP
all occur in the cytosol. Thus, depending on the
metabolic demand of the organism the PPP may
provide precursors for biosynthesis or metab-
olites for glycolysis. However, the above reaction
sequence of the non-oxidative branch of the PPP
(Fig. 4) is based on an interpretation of the
results of catalysis by liver and pea enzyme prep-
arations incubated with variously labelled 14C-
ribose phosphate substrates and the resultant for-
mation of 14C-labelled fructose 6-phosphate.
These reactions were tentatively attributed to cat-
alysis by TK and TA [40, 64]. The conclusion
concerning the nature and order of these reac-
Fig. 5. TK motif. The sequences are taken from the multiple sequence alignment in Schenk et al. [138]. The sequences selected for
illustration are from the same organisms as in Fig. 2 and the consensus sequence based on the entire alignment in Schenk et
al. [138] is shown.
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tions (Fig. 4) is still controversial because the
degree of 14C isotope labelling and its distri-
bution in carbon atoms 1 and 3 of fructose 6-
phosphate diered from that predicted by the
reaction sequences shown in Fig. 4 [40, 64, 180].
One reason for those discrepancies might be that
TK appears to catalyse exchange reactions much
faster than the non-oxidative PPP flux rates [35].
Datta and Racker [24] reported that the equili-
brium constant for reactions catalysed by TK is
close to unity, indicating that the relative concen-
trations of substrates and products control the
direction of the reaction. This result is consistent
with a requirement for metabolic flexibility. It
has been suggested for S. cerevisiae that TK and
TA control the flux of metabolites through the
non-oxidative limb of the PPP [133, 144]. NMR
studies on human hemolysates have demon-
strated that TK has a high flux-control coe-
cient, indicating that this enzyme exhibits a
controlling function on the PPP in
erythrocytes [5]. Although this pathway is ubiqui-
tous there is evidence that its metabolic activity
in higher organisms is tissue-dependent, e.g. its
activity is low in skeletal muscle and liver, but
very high in adipose tissue, mammary glands and
the adrenal cortex, where large amounts of
NADPH (generated in the oxidative branch of
the PPP) are required for the reductive synthesis
of fatty acids and steroids from acetyl CoA. The
PPP is also active in human erythrocytes where
the NADPH is required to maintain reduction of
glutathione for the detoxification of reactive oxy-
gen species.
Several studies have shown that PPP activity is
greatly increased in rabbit, rat and mouse mature
corneal epithelia [49, 88, 131]; in bovine corneal
epithelium 35% of glucose is metabolised via the
PPP [78]. It is very likely that this high activity
reflects the need of the corneal tissue for su-
cient amounts of reducing equivalents (NADPH)
for the prevention of damage by H2O2 and free
radicals formed by UV radiation [49, 131]. In
newborn mice a great increase in TK synthesis
was observed at the time of the eye opening [131].
In the corneal epithelium of mouse 10% of the
soluble protein is TK [131]. While TK is the rate-
limiting enzyme in the nonoxidative link of the
PPP (see above), it is yet unknown if other
enzymes of the PPP are also expressed in such
great abundance in these tissues. The high con-
centration of TK in ocular tissues suggests the
proposition that this enzyme might also be struc-
turally important for light refraction, tissue trans-
parency and light absorption, i.e. TK might be
an enzyme-crystallin of the lens, similar to other
putative enzyme-crystallins such as glutathione S-
transferase [131].
Although data about plant TKs are scarce it is
clear that this enzyme forms an important link
between the Calvin cycle and carbohydrate
metabolism (e.g. PPP and glycolysis) on the one
hand and on the other hand anabolic pathways
leading to the formation of nucleic acids, amino
acids and many derivatives of these. In the desic-
cation-tolerant plant C. plantagineum one TK
gene is constitutively expressed. Two additional
ones, however, are synthesized only during the
process of rehydration [4] perhaps in order to
increase the flux of carbohydrates through the
PPP to satisfy the increased demand for nucleo-
tides and amino acids during the accelerated
growth of rehydrating plants.
A mainly anabolic role can also be inferred for
the recP gene product from Streptococcus pneu-
moniae. A sequence comparison reveals that the
recP gene, whose product is involved in the
recombination process [126], is likely to encode a
TK [138, 155]. It is postulated that this enzyme is
required during recombination for the synthesis
of abundant quantities of ribose 5-phosphate for
the subsequent generation of phosphoribosyl pyr-
ophosphate, a precursor in the biosynthesis of
nucleotides.
4. Catalytic mechanism of TK
TK catalyses the interconversion of monosac-
charides by transferring glycolaldehyde moieties
from ketose donors to aldose acceptors (Fig. 4).
The catalytic mechanism is depicted in Fig. 3.
The crystal structure of S. cerevisiae TK reveals
that the cofactor Mg2+-ThDP complex in this
enzyme is bound in a hydrophobic pocket at the
interface of the two subunits and only C2 of the
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thiazolium ring is accessible from the
solvent [93, 101, 111]. The abstraction of the pro-
ton from C2 is the initial step in catalysis in all
studied ThDP-dependent enzymes. For TK the
following model has been proposed for the mech-
anism that leads to the formation of the carba-
nion (ThDP ylide in Fig. 3) [142].
The invariant residue Glu418 (unless otherwise
stated the numbers refer to the S. cerevisiae
sequence [155]) is suciently close to form a
hydrogen bond with N1 0 of the aminopyrimidine
ring. The importance of this interaction has been
demonstrated by experiments in which the puta-
tive hydrogen bond was disrupted either by
deaza analogues of the cofactor [45, 84] or by
site-directed mutagenesis of residue 418 [175]. It
is proposed that this hydrogen bond promotes
the generation of a resonance form with a posi-
tively charged imino-group at the 4 0-position of
the pyrimidine ring. The side chain of His481 is
close to this charged imino group and it has been
suggested that His481 (which corresponds to
His113 or His114 in Zymomonas mobilis PDC
which have been shown to be involved in various
aspects of PDC function [19, 139]) may abstract
the proton from the imino group, which would
increase the pKa of the imino group suciently
that it could in turn remove the proton from the
C2 of the thiazolium ring. One problem of this
mechanism is that in mammalian TKs His481 is
replaced by a glutamine [138], rendering the pro-
posed catalytic function of His481 questionable.
Singleton and his colleagues [149] have made a
mutant human TK in which this residue (Gln428
in mammalian TKs) has been replaced by a histi-
dine (the residue in all nonmammalian TKs in
this position). It displays only 30% of the wild-
type activity, consistent with the proposition that
the functions of these corresponding residues in
mammalian and nonmammalian TKs are not
identical. The authors have postulated that this
glutamine might be involved in stabilising and
orienting a water molecule required for
catalysis [149]. However, without the crystal
structure of a mammalian TK the eects of the
observed dierences at this residue remain specu-
lative.
After formation of the ThDP ylide, binding of
the donor substrate and a nucleophilic attack on
the carbonyl carbon atom of the substrate are
the next steps in catalysis. The three-dimensional
crystallographic data of S. cerevisiae TK clearly
indicate a substrate channel [111, 112]. It has
been suggested that an interaction between the
C1-hydroxyl group of the substrate and the side
chain of the invariant residue His103 may be
required for optimal positioning of the donor
substrate for the nucleophilic attack [176]. The
formation of an adduct between the donor sub-
strate and cofactor (intermediate 1 in Fig. 3) is
accompanied by the protonation of the carbonyl
oxygen of the substrate. Again, His481 has been
proposed as the most likely candidate for the
proton donor according to the structure of S.
cerevisiae TK [142]. In a recent study carried out
by Schneider’s group His481 was replaced by ala-
nine, serine and glutamine [177]. The three
mutants had a drastic decrease in catalytic ac-
tivity and the anity for the donor substrate was
strongly reduced. These results are consistent
with the proposition that His481 is likely to be
important for the stabilisation of intermediate 1
(Fig. 3), at least in yeast TK. Subsequently, the
abstraction of the proton from the C3-hydroxyl
group of the substrate, possibly mediated by a
concerted action of the invariant residues His30
and His263 [177], leads to the cleavage of the ad-
dition compound and the release of the first pro-
duct, an aldose sugar. Concomitantly, the 2-a-
carbanion of the reaction intermediate a,b-dihy-
droxyethyl-ThDP (DHEThDP, also named the
‘active glycolaldehyde’) is formed. Recently, it
has been shown that DHEThDP can act as the
donor substrate for TK from baker’s yeast with
a reaction rate that is much the same as that of
natural substrates [146, 163]. These results suggest
that the deprotonation that leads to the for-
mation of the 2-a-carbanion is not a rate-limiting
step in TK catalysis.
The generation of this 2-a-carbanion is com-
mon to all reactions catalysed by ThDP-depen-
dent enzymes. In TK this carbanion reacts with
an aldose acceptor substrate to form intermediate
2 (Fig. 3). The crystal structure of S. cerevisiae
TK with bound acceptor substrate has indicated
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which amino acid residues of the substrate chan-
nel may interact with the substrate [112].
However, these structural data do not necessarily
reflect the actual geometry during catalysis
because this enzyme–substrate complex is lacking
the glycolaldehyde moiety attached to ThDP
(DHEThDP, see above). The glycolaldehyde moi-
ety is transferred to the acceptor to form a new
ketose sugar and simultaneously regenerate
ThDP. This second part of catalysis is essentially
a reversal of the first part and it is therefore
likely that the same side chains will be involved
in the proton transfer. The release of the first
product, followed by the binding of the second
substrate implies that the active site is accessible
from the solvent during this exchange. It is not
yet understood how the enzyme can stabilise the
negatively charged reaction intermediate in this
‘‘open’’ conformation.
The majority of the evidence for the catalytic
mechanism of TK has been obtained from
structural studies of the yeast enzyme [e.g. 142].
Kinetic studies of DHAS from C. boidinii [74]
and TK from E. coli [50] have shown that the
properties of these enzymes are consistent with
this ‘‘ping-pong’’ mechanism [22]. Most of the
kinetic analyses have been focussed on the in-
vestigation of the interactions between TK and
its substrates [e.g. 143] and the binding of
ThDP to the enzyme [e.g. 11, 32, 161]. Yeast
TK displays marked hysteresis [110] in binding
ThDP [32] as does human TK [10, 148, 161]. In
the case of the human enzyme, binding is so
slow at the concentration of ThDP in erythro-
cytes (200 nM in health [159] and as low as 40
nM in thiamin deficiency [160]) that the
measurement of an apparent Km value for the
binding of Mg2+-ThDP to apoTK is techni-
cally demanding [161]. After one hour of incu-
bation the apparent Km value can be measured
at 65214 nM [161] and after a three-hour in-
cubation the value decreases further, to 1529
nM [137, 140], making the binding of ThDP to
TK tight as well as slow.
5. Industrial uses of TK
It has been proposed that an increase in the
PPP activity would increase the fermentation e-
ciency of S. cerevisiae for particular industrial ap-
plications. However, all attempts to produce
large quantities of ethanol by means of recombi-
nant yeasts overexpressing TK and TA have
failed thus far [e.g. 96, 168]. Nonetheless, TK
finds an increasing number of applications for
industrial purposes, in particular in the synthesis
of chemicals. One example is the biosynthesis of
the aromatic amino acids L-phenylalanine, L-
tryptophan and L-tyrosine from D-glucose [e.g.
39]. These amino acids are used as precursors for
the organic synthesis of various products; e.g. L-
phenylalanine can be transformed into the artifi-
cial sweetener aspartame [166], L-tryptophan into
the dye indigo [34] and L-tyrosine into eumela-
nin, a UV-absorbing substance [26]. Attempts to
increase the conversion of D-glucose into aro-
matic amino acids originally focussed on the
enzyme 3-deoxy-D-arabino-heptulosonic acid 7-
phosphate (DAHP) synthase [121], the first
enzyme unique to the common pathway of aro-
matic amino acid biosynthesis [174]. DAHP
synthase catalyses the irreversible condensation
of phosphoenolpyruvate with D-erythrose 4-
phosphate resulting in the formation of DAHP
and inorganic phosphate [121]. However, the
supply of D-erythrose 4-phosphate requires the
reactions of the PPP, particularly those catalysed
by TK, and in an E. coli strain overexpressing
TK the proportion of D-glucose directed towards
synthesis of aromatic amino acids is significantly
increased [29, 47].
TK is also an important biocatalyst in stereo-
specific carbon–carbon bond synthesis [60]. TK
accepts a large number of aldehydes as
substrates [59, 67, 106], in particular those con-
taining an a-hydroxy group in 2R configuration;
the products are ketoses with a 3 S,4R configur-
ation (threo configuration) [27, 31]. As an
example, TK from spinach can catalyse a reac-
tion between 2,3-dihydroxybutyraldehyde and
hydroxypyruvate, yielding a mixture of 6-deoxy-
D-fructose and 6-deoxy-L-sorbose [53] which can
serve as precursors of 2,5-dimethyl-4-hydroxy-
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3(2H)-furanone (furaneol), an important indus-
trial aromatic product with caramel-like flavour
used in the food industry [54]. One of the major
problems for the large scale industrial use of TK-
catalysed biotransformations is that high concen-
trations of substrate strongly decrease the turn-
over number [9, 103, 137]. Using hydroxypyruvate
and glycolaldehyde as substrates Mitra et al. [103]
analysed limitations for an optimal turnover of
product (see above). At high concentrations
(500 mM) of the acceptor substrate (glycolalde-
hyde) TK was inactivated. However, develop-
ment of an enzyme-membrane reactor which
keeps the concentrations of substrates and pro-
ducts low greatly increases the half-life of TK
and the yield of reaction products [9].
6. Variant forms of TK
The first report of apparent multiple forms of
TK was published almost 30 years ago by Kiely
et al. [77]. These authors showed that the
enzyme, purified from C. utilis, eluted in three
peaks from a DEAE-Sephadex column.
However, another group were able to find only
one peak of C. utilis TK activity eluting from the
ion exchange column [79]. Another example of
multiple forms was found during chromatog-
raphy of human erythrocyte TK on a Mono P
column, which separates the enzyme activity into
three peaks [158] but amino acid analysis and im-
munological studies indicated that the three
peaks appeared to be the same protein. Based on
their separation on phosphocellulose and thermo-
stability, multiple forms of TK have also been
reported for this enzyme purified from baker’s
yeast, the livers of rat and pig and several organs
of rabbit [89]. It was also shown that the dier-
ent forms are not an artefact of the purification
procedures. The same group later reported dier-
ent morphologies for the crystals of the multiple
TK forms [90]; these TK variants can intercon-
vert, indicating that they are not dierent iso-
zymes. Kuimov et al. [90] speculated that
posttranslational modifications or a reversible as-
sociation with a ligand may be responsible for
the existence of multiple TK forms but as yet no
solid evidence in support of this proposal has
been published.
However, it has become evident that some
organisms do possess true variant forms of TK.
In 1993 two groups independently cloned two S.
cerevisiae TK genes which have approximately
70% identity [132, 155]. This was the first convin-
cing evidence for genetic heterogeneity of any
TK. Since then two genetic variants have been
found in the bacterium E. coli [68, 152] and three
in the plant C. plantagineum [4]. While it is still
unclear why E. coli and S. cerevisiae have two
dierent TKs it could be shown that only one of
the three TK forms in C. plantagineum is
expressed constitutively. The remaining two
forms appear to be involved specifically in the
rehydration process [4].
The occurrence of variant forms of human TK
has been controversial since it was first reported
by Blass and Gibson in 1977 [7]. They measured
the anity of apoTK for its cofactor ThDP,
using unpurified enzyme from cultured human
fibroblasts. Their results showed that the enzyme
isolated from healthy controls had a higher a-
nity for the cofactor than the enzyme extracted
from fibroblasts of patients suering from the
neurodegenerative disorder Wernicke–Korsako
(WK) syndrome. The authors suggested that the
patients were genetically predisposed to this dis-
order. Their results were later supported by
Mukherjee et al. [107] although the observed
dierence between the apparent cofactor binding
constants for patients and controls was much
smaller. In this laboratory TK isolated from
erythrocytes of WK syndrome patients and con-
trols did not display any variation in ThDP
anity [113]. It was pointed out that variant
apparent Km values may be due to variations in
the applied assay conditions given the tight, slow
binding of apoTK with the Mg2+-ThDP
complex [161].
Studies applying isoelectric focussing did not
satisfactorily resolve the controversy about a
putative polymorphism of human TK. When a
pure erythrocyte TK preparation from a single
individual was analysed by application of this
method, the enzyme resolved into three to eight
distinct bands [73]. Focussed bands containing
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TK were detected by a specific activity stain [182].
Multiple bands of isoelectrically focussed TK
have also been found in human leukocytes [105]
and rat liver [116]. A comparison of the banding
patterns of focussed TK isolated from red blood
cells of WK syndrome patients and healthy con-
trols led to the report that one particular banding
pattern apparently correlates with this
disorder [113]. However, Kaufmann et al. [75]
reexamined the pattern of erythrocyte TK from
63 healthy subjects. While seven bands could be
readily reproduced from all samples four ad-
ditional bands occurred in some but not in other
samples. The fluctuation in the banding pattern
of healthy subjects led to the conclusion that the
absence or presence of particular bands was not
a sucient proof for the occurrence of genetic
variants of human TK. Blansjaar et al. [6] com-
pared isoenzyme patterns of WK patients, their
relatives, alcoholics and healthy subjects and they
found no evidence for a genetic variation. More
importantly, the cDNA encoding TK has been
sequenced from two healthy controls and two
patients suering the WK syndrome and no con-
sistent non-silent mutations distinguished these
two groups [100]. However, none of these studies
has ruled out the possibility that dierences in
postranslational modifications could be respon-
sible for observed variant forms of TK. For
example, purified rat liver TK has been phos-
phorylated in vitro by protein kinase C and to a
smaller extent by cAMP-dependent protein
kinase and casein kinase II [151] but evidence of
phosphorylation of TK in vivo is yet to be pub-
lished. The results of such experiments are
eagerly awaited since in vitro phosphorylation
decreased TK activity [151].
While the possibility of genetic variations of
human TK has not been ruled out, it seems unli-
kely that multiple genes encode this enzyme.
Using as a probe DNA containing part of the
human TK gene sequence (cloned from a human
liver genomic DNA library [1]), the location of
the TK gene has been mapped; only one locus
hybridised to the probe [92]. Unless there is a dis-
tinctly dierent form of TK (which would not
hybridise with the chosen genomic DNA probe)
it is very likely that there is only one gene encod-
ing human TK. However, the recent cloning of
transcripts of human TK-related genes from
dierent tissues has raised the possibilities of
alternative splicing and formation of
heterodimers [23]. A comparison with the
sequences of known TKs showed that the TK-re-
lated genes contain the ThDP-binding (Fig. 2)
and TK (Fig. 5) motifs. However, since several
important amino acid residues are missing from
the translated TK-related sequences these puta-
tive gene products may be nonfunctional.
Additional sequence variations were discovered
between TK-related genes from dierent tissues
(heart and brain). Coy et al. [23] hypothesise that
dierent forms of TK activity could be due to
allelic variations of the TK-related gene, but so
far no expression product of this gene has been
reported.
7. Potential associations of TK activity with
disorders consequent to thiamin-deficiency
Like other ThDP-dependent enzymes, the ac-
tivity of TK is decreased in conditions of thiamin
deficiency. The best known thiamin deficiency
disease, beriberi, has been little studied as to its
enzymologic consequences since the most consist-
ent pathology is in fine peripheral nerves which
make poor samples from which to isolate
enzymes. However, the WK syndrome causes
characteristic, localised brain pathology and the
consequences of thiamin deficiency for the brain
have been well studied. Of all the ThDP-depen-
dent enzymes in the brain, TK activity decreases
first and returns last following thiamin repletion
of a thiamin-deficient animal [44, 99, 164].
However, it appears that these changes in TK ac-
tivity do not directly lead to the localised neuro-
pathology because the changes in activity
correlate poorly with changes in the manifes-
tation of disease [44]. Moreover TK protein and
TK mRNA are distributed unequally amongst
rat brain nuclei, but their decreases in the thia-
min deficient rat brain do not correlate with the
sites of brain pathology [145]. In fact, a-ketoglu-
tarate dehydrogenase (KGDH) is the ThDP-
dependent enzyme whose activity varies, in thia-
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min deficiency, in the closest temporal relation-
ship with the manifestations of the disease in ex-
perimental rats [16, 17, 43].
Erythrocyte TK activity is measured to assess
human thiamin deficiency and assays of hemoly-
sate TK activity in the absence and presence of
cofactor added in vitro allow the inference that
some apoTK accumulates as holoTK decreases
in human thiamin deficiency [76, 114, 123]. Indeed
the rapid symptomatic response of thiamin-de-
ficient patients to therapeutic thiamin is paralled
by the apparent conversion of erythrocyte
apoTK to holoTK in vivo within a period as
brief as 30 min [123]. Moreover, the total eryth-
rocyte TK activity is restored to the thiamin-re-
plete levels, consistent with the retention of total
TK protein throughout the period of thiamin de-
ficiency. However, in hemolysates from thiamin-
deficient patients, not all the apoTK can be reac-
tivated in vitro, for reasons that are as yet
unclear [41, 123]. Since mature erythrocytes do
not synthesise protein, the half-life of erythrocyte
TK protein must be similar to or greater than
the half-life of the erythrocyte, i.e. 50 days in
humans. The half-life of TK protein in other tis-
sues might be quite dierent from that of eryth-
rocytes. It has been measured in rat heart, where
it is 68 hours [87] and in cultured human lym-
phoblasts, where it was only 1.4 hours, whether
the culture medium was replete or deficient in
thiamin [119]. However, thiamin deficiency
appeared to decrease the rate of TK protein syn-
thesis in these cultured lymphoblasts [119]. Such
studies need to be repeated in whole animals and
other cultured cells to determine whether the
results are peculiar to lymphoblasts.
8. TK changes in Alzheimer’s disease patients
In brains and other tissues from Alzheimer’s
disease patients examined post mortem, there is
decreased activity of TK [42]. Moreover, isoelec-
tric focussing has detected a change in TK
extracted from fibroblasts grown from
Alzheimer’s patients [117]. This change could be
attributed to proteolytic cleavage of TK resulting
in a shorter subunit that retained some activity.
Subsequently, it has been shown that a cysteine
proteinase in the fibroblasts of Alzheimer’s
patients is responsible for this activity [118].
Thus, these changes in TK activity appear to rep-
resent a marker for Alzheimer’s disease, but there
is not yet any evidence that they are causally re-
lated to the pathogenesis of the disease.
9. Conclusions and future directions
Recent analyses of the catalytic mechanism of
TK have derived an increasingly complex model
which has been partly explained by the structure
of the S. cerevisiae TK at 2.0 A˚ resolution.
However, the structure has posed new questions.
It has been observed that the two active sites in
TK display non-equivalence although, according
to the crystal structure, they appear to be identi-
cal. Neither the underlying cause nor the signifi-
cance for the occurrence of this phenomenon is
well understood; introduction of specific mu-
tations into TK and/or crystallographic resol-
ution of a binary complex of TK with a bound
donor substrate analogue will be necessary to
maintain the proposition that this apparent non-
equivalence of the two active sites depends upon
an alternating direction of electron flow from one
ThDP to the other ThDP via hydrogen bonds
which link these catalytic centres. Elucidation of
the structure of a mammalian TK is eagerly
awaited. This will not only shed light on mechan-
istic properties of this enzyme but also reveal
insight into functional variations observed
between mammalian and nonmammalian TKs,
e.g. substrate specificity and cofactor binding.
TK actvity is crucial for the flux of carbo-
hydrates through the non-oxidative limb of the
PPP and understanding its control is critical to
the industrial application of TK in the pro-
duction of biosynthetic molecules. Recombinant
mutants possessing desired features such as
broader substrate range, higher thermostability
or increased turnover rate may be designed for
use in industrial processes. Generation of recom-
binant microbial systems expressing TK has com-
menced and some encouraging results have been
reported. Recent analyses have outlined the
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requirements for a bioreactor carrying out TK-
catalysed reactions; further optimisation for
large-scale operation at high concentrations of
reactants would be facilitated by engineering TK
to enhance the anity for substrates such as
hydroxypyruvate and glycolaldehyde, while
increasing the turnover rate and decreasing the
potential for substrate inhibition by hydroxypyr-
uvate.
The role of TK in the PPP has been well
recognised for more than 40 years. Interestingly,
recent research has indicated that TK may have
not only a metabolic role but also a structural
one, at least in the cornea. It is not yet known if
the large abundance of TK in these cells is due
to the proposed structural function, or if it is
simply a reflection of the eye’s requirement for a
high PPP activity in order to maintain the necess-
ary reducing environment. Measurements of the
levels of other enzymes of the PPP, in particular
that of glucose 6-phosphate dehydrogenase (the
rate-limiting enzyme of the oxidative branch)
would help to clarify this issue.
It has become increasingly clear that during
thiamin deficiency in humans the changes of TK
activity do not reflect the actual course of the
disorder. Furthermore, the search for human TK
genetic variations associated with thiamin de-
ficiency has failed. Thus, unless it can be shown
in vivo that tissue or individual specific variations
or posttranslational modifications cause changes
in TK activity, there is no evidence for a direct
involvement of TK in the pathogenesis of dis-
ease. One further possible source of human TK
variants is the finding of alternatively spliced
transcripts of a TK-related gene, but it is yet to
be shown that these transcripts are translated
and that the product has TK activity. However,
partial proteolytic cleavage of TK does serve as a
marker for Alzheimer’s disease and hence TK
will remain an interesting candidate for neurobio-
chemical studies.
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